Nonpartisan civic infrastructure
AllCiv
·
Legis1
Public
·
Reps, Candidates, Orgs
AllCiv
Beta
Citizen Portal
Home
News
My Dashboard
My Updates
My Yard
My Reps
My Elections
My Issues
My Communities
My Organizations
My Laws & Bills
My Messages
My Calendar
My Profile
Explore
Elected Offices
Representatives
Elections
Candidates
Laws, Bills & Regs
Civic Maps
Civic Calendar
Rankings
Upgrade — $8/mo
?
Sign in or sign up
Access dashboard →
H.R. 7383
Bill
Federal
House
In Committee
To amend the Federal Food, Drug, and Cosmetic Act to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.
About This Bill
Committee
Latest Action · February 16, 2024
Referred to the Subcommittee on Health.
Congress
118th (2023–2025)
Introduced
February 15, 2024
Sponsor
Rep. Doris Matsui
D
Cosponsors (2)
0D
2R
View PDF ↗
Summary
Full Text
Comments
Annotations
Full Text
The official full text of this bill isn’t available inside AllCiv yet. Read it on Congress.gov:
Introduced in House (2024/02/15)
· Feb 15, 2024
Congress.gov ↗
A plain-language summary is on the
Summary
tab — you can highlight and annotate it there.
Take Action
Your position
Support
Oppose
Add a comment
Sign in
to comment on this bill.
Annotate the text
Highlight any passage on the
Summary
or
Full Text
tab to attach a note. Annotations appear on the
Annotations
tab.
Home
News
Explore
Updates
Account